In addition to affecting the activity of ANS, sleep also exerts a significant regulatory effect on glycemic control by influencing the balance and levels of hormones including leptin, growth hormone-releasing peptide, insulin and cortisol (Balbo et al., 2010), which enhances the association between HRV metrics during sleep and glycemic control of T2DM patients. Here, GHRL is linked to type 2 diabetes mellitus.